American Healthcare REIT ("AHR") Announces Second Quarter 2024 Results; Increases Full Year 2024 Guidance
American Healthcare REIT (NYSE: AHR) reported strong Q2 2024 results and increased its full-year 2024 guidance. Key highlights include:
- GAAP net income of $2.9 million, up from a $11.9 million loss in Q2 2023
- Normalized FFO of $0.33 per diluted share
- Total portfolio Same-Store NOI growth of 15.7%, driven by strong performance in SHOP (49.1%) and ISHC (24.1%) segments
- Increased full-year 2024 Same-Store NOI growth guidance to 12-14% from 5-7%
- Raised NFFO guidance to $1.23-$1.27 per share from $1.18-$1.24
- Improved Net-Debt-to-Adjusted EBITDA from 6.4x to 5.9x
Management cited strong demand for healthcare real estate and expects elevated Same-Store NOI growth to continue due to the demand-supply imbalance in long-term care.
American Healthcare REIT (NYSE: AHR) ha riportato risultati solidi per il secondo trimestre del 2024 e ha aumentato la sua guida annuale per il 2024. Le principali novità includono:
- Utile netto GAAP di $2,9 milioni, in aumento rispetto a una perdita di $11,9 milioni nel secondo trimestre del 2023
- FFO normalizzato di $0,33 per azione diluita
- Crescita del NOI Same-Store dell'intero portafoglio del 15,7%, trainata da un'ottima performance nei segmenti SHOP (49,1%) e ISHC (24,1%)
- Aumento della stima di crescita del NOI Same-Store per l'intero anno 2024 a un intervallo del 12-14% rispetto al precedente 5-7%
- Aumento della proiezione NFFO a $1,23-$1,27 per azione rispetto a $1,18-$1,24
- Miglioramento del rapporto Debito Netto su EBITDA Rettificato da 6,4x a 5,9x
La direzione ha citato una forte domanda per il settore immobiliare sanitario e prevede che la crescita del NOI Same-Store rimarrà elevata a causa dell'imbalance tra domanda e offerta nella cura a lungo termine.
American Healthcare REIT (NYSE: AHR) reportó sólidos resultados para el segundo trimestre de 2024 y aumentó su guía para todo el año 2024. Los aspectos más destacados incluyen:
- Ingresos netos GAAP de $2,9 millones, en comparación con una pérdida de $11,9 millones en el segundo trimestre de 2023
- FFO normalizado de $0,33 por acción diluida
- Crecimiento del NOI Same-Store del portafolio total del 15,7%, impulsado por un sólido rendimiento en los segmentos SHOP (49,1%) e ISHC (24,1%)
- Aumento de la guía de crecimiento del NOI Same-Store para todo el año 2024 al 12-14% en comparación con el 5-7% anterior
- Aumento de la proyección de NFFO a $1,23-$1,27 por acción en comparación con $1,18-$1,24
- Mejora de la relación Deuda Neta sobre EBITDA Ajustado de 6,4x a 5,9x
La dirección citó una fuerte demanda de bienes raíces de atención médica y espera que el crecimiento del NOI Same-Store se mantenga elevado debido al desequilibrio entre la demanda y la oferta en la atención a largo plazo.
미국 건강 관리 REIT (NYSE: AHR)는 2024년 2분기 강력한 실적을 보고하고 연간 가이드를 상향 조정했습니다. 주요 내용은 다음과 같습니다:
- GAAP 순이익 290만 달러, 2023년 2분기 1190만 달러 손실에서 증가
- 정상화된 FFO 주당 $0.33
- 전체 포트폴리오의 동종 매장 NOI 성장률 15.7%, SHOP(49.1%) 및 ISHC(24.1%) 부문의 강력한 실적에 힘입음
- 2024년 전체 연도 동종 매장 NOI 성장 가이드를 5-7%에서 12-14%로 상향 조정
- NFFO 가이드를 주당 $1.23-$1.27로 증가, 이전 $1.18-$1.24에서 상향
- 순 부채 대비 조정 EBITDA 비율이 6.4배에서 5.9배로 개선됨
경영진은 의료 부동산에 대한 강한 수요를 언급하며 장기 요양에서 수요 공급 불균형으로 인해 동종 매장 NOI 성장이 계속될 것으로 예상하고 있습니다.
American Healthcare REIT (NYSE: AHR) a annoncé de bons résultats pour le deuxième trimestre de 2024 et a relevé ses prévisions pour l'année 2024. Les points forts comprennent :
- Un bénéfice net GAAP de 2,9 millions de dollars, contre une perte de 11,9 millions de dollars au deuxième trimestre 2023
- FFO normalisé de 0,33 $ par action diluée
- Une croissance du NOI Same-Store du portefeuille total de 15,7%, soutenue par une forte performance dans les segments SHOP (49,1%) et ISHC (24,1%)
- Prévisions de croissance du NOI Same-Store pour l'année 2024 relevées à 12-14% contre 5-7%
- Prévisions de NFFO augmentées à 1,23-1,27 $ par action contre 1,18-1,24 $
- Amélioration du ratio Dette Nette à EBITDA Ajusté de 6,4x à 5,9x
La direction a cité une forte demande pour l'immobilier de santé et s'attend à ce que la croissance élevée du NOI Same-Store se poursuive en raison du déséquilibre entre l'offre et la demande dans les soins de longue durée.
American Healthcare REIT (NYSE: AHR) hat starke Ergebnisse für das zweite Quartal 2024 gemeldet und seine Jahresprognose für 2024 angehoben. Die wichtigsten Highlights umfassen:
- GAAP-Nettoergebnis von 2,9 Millionen USD, im Vergleich zu einem Verlust von 11,9 Millionen USD im zweiten Quartal 2023
- Normalisiertes FFO von 0,33 USD pro verwässerter Aktie
- Wachstum des NOI Same-Store des gesamten Portfolios von 15,7%, getragen von einer starken Leistung in den Segmenten SHOP (49,1%) und ISHC (24,1%)
- Erhöhte Prognose für das NOI-Wachstum im Jahr 2024 für Same-Stores auf 12-14% von zuvor 5-7%
- Erhöhung der NFFO-Prognose auf 1,23-1,27 USD pro Aktie von 1,18-1,24 USD
- Verbesserung des Verhältnisses von Nettoverschuldung zu bereinigtem EBITDA von 6,4x auf 5,9x
Das Management verwies auf die starke Nachfrage nach Immobilien im Gesundheitssektor und erwartet, dass das hohe NOI-Wachstum in den gleichen Geschäften aufgrund der Ungleichheit von Angebot und Nachfrage in der Langzeitpflege anhält.
- GAAP net income increased to $2.9 million from a $11.9 million loss in Q2 2023
- Total portfolio Same-Store NOI growth of 15.7%, with SHOP segment growing 49.1% and ISHC segment growing 24.1%
- Full-year 2024 Same-Store NOI growth guidance increased to 12-14% from 5-7%
- NFFO guidance raised to $1.23-$1.27 per share from $1.18-$1.24
- Net-Debt-to-Adjusted EBITDA improved from 6.4x to 5.9x
- Outpatient Medical segment experienced a 0.4% decline in Same-Store NOI
- Increased interest expense expectations partially offset the NFFO guidance increase
Insights
American Healthcare REIT's Q2 2024 results show significant improvement, with a shift from a
The company has increased its full-year 2024 guidance, raising NFFO expectations from
The reduction in Net-Debt-to-Annualized Adjusted EBITDA from 6.4x to 5.9x indicates improving financial health. However, investors should note the partial offset to NFFO guidance due to increased interest expense expectations, which could impact profitability if interest rates continue to rise.
The robust performance in AHR's SHOP and ISHC segments underscores a significant demand-supply imbalance in long-term care real estate. With Same-Store NOI growth of
The company's strategy of hands-on asset management is yielding results, with increased occupancy and effective expense management. The guidance upgrade suggests management expects this trend to continue, potentially leading to enhanced pricing power in these segments.
However, the flat to slightly negative performance in the Outpatient Medical segment (
Overall, AHR's portfolio seems well-positioned to capitalize on the growing demand for healthcare-related real estate, particularly in the senior living and integrated health campus sectors.
Key Highlights:
- Reported GAAP net income attributable to common stockholders of
$0.01 - Reported Normalized Funds from Operations attributable to common stockholders ("NFFO") of
$0.33 - Reported GAAP net income of
$2.9 million $(11.9) million - Achieved total portfolio Same-Store Net Operating Income ("NOI") growth of
15.7% for the three months ended June 30, 2024 compared to the same period in 2023, highlighted by49.1% and24.1% Same-Store NOI growth from its senior housing operating properties ("SHOP") and integrated senior health campuses ("ISHC"), respectively. - Increased total portfolio Same-Store NOI growth guidance for the year ending December 31, 2024 by 700 basis points at the midpoint from a range of
5.0% to7.0% to a revised range of12.0% to14.0% , due to better-than-expected operations across all of its property segments for the year ending December 31, 2024. - Increased NFFO guidance for the year ending December 31, 2024 by
$0.04 $1.18 $1.24 $1.23 $1.27 - Reported a 0.5x improvement in the Company's Net-Debt-to-Annualized Adjusted EBITDA from 6.4x as of March 31, 2024 to 5.9x as of June 30, 2024.
"Our first year as a listed company is off to a great start. Demand for healthcare real estate is evident in our portfolio performance. Growth in the first half of 2024 is exceeding the expectations we set at the beginning of the year prompting our upward revisions to Same-Store NOI growth guidance and NFFO guidance. As we plan for the balance of the year and into 2025, we expect the elevated levels of Same-Store NOI growth to persist due to the demand-supply imbalance present in long-term care," said Danny Prosky, the Company's President and Chief Executive Officer.
Second Quarter and Year-to-date 2024 Results
The Company's Same-Store NOI growth results are detailed below. Hands-on asset management resulting in increased occupancy and expense management continues to support bottom-line results.
SS NOI Growth Rates: Quarter Ended June 30, 2024 Relative to Quarter Ended June 30, 2023 | |
Segment | NOI Growth/(Decline) |
ISHC | 24.1 % |
Outpatient Medical | (0.4) % |
SHOP | 49.1 % |
Triple-Net Leased Properties | 2.9 % |
Total Portfolio | 15.7 % |
SS NOI Growth Rates: Six Months Ended June 30, 2024 Relative to Six Months Ended June 30, 2023 | |
Segment | NOI Growth |
ISHC | 22.0 % |
Outpatient Medical | 0.3 % |
SHOP | 41.4 % |
Triple-Net Leased Properties | 3.6 % |
Total Portfolio | 14.4 % |
"Property performance across our ISHC and SHOP segments remains strong. Having built sector-leading occupancy through the first half of 2024, we believe we have the opportunity to further enhance pricing power strategies to continue strengthening performance across our ISHC and SHOP segments. We believe our occupancy gains in addition to positive RevPOR growth in the first half of the year will continue to benefit Same-Store NOI growth results in the back half of 2024 and into early 2025," said Gabe Willhite, the Company's Chief Operating Officer.
Full Year 2024 Guidance
The Company's following guidance for the year ending December 31, 2024, originally announced on March 21, 2024 in the Company's Fourth Quarter 2023 Earnings Release, has been revised to reflect management's improved outlook. Revised guidance ranges are detailed below:
Revised Full Year 2024 Guidance | Prior Full Year 2024 Guidance | ||
Metric | Midpoint | FY 2024 Range | FY 2024 Range |
NAREIT FFO per share | |||
NFFO per share | |||
Total Portfolio SS NOI Growth | 13.0 % | ||
Segment-Level SS NOI | |||
Growth / (Decline): | |||
ISHC | 19.0 % | ||
Outpatient Medical | (0.3) % | (0.5)% to | (0.5)% to |
SHOP | 47.5 % | ||
Triple-Net Leased Properties | 2.0 % | ||
____________
Certain of the assumptions underlying the Company's 2024 guidance can be found within the Non-GAAP reconciliations in this earnings release and in the appendix of the Company's Second Quarter 2024 Supplemental Financial Information ("Supplemental"). A reconciliation of Net income (loss) calculated in accordance with GAAP to NAREIT FFO and NFFO can be found within the Non-GAAP reconciliations in this earnings release. Non-GAAP financial measures and other terms, as used in this earnings release, are also defined and further explained in the Supplemental. The Company does not provide guidance for the most comparable GAAP financial measures of total revenues and property operating and maintenance expenses. Additionally, a reconciliation of the forward-looking Non-GAAP financial measures of Same-Store NOI growth to the comparable GAAP financial measures cannot be provided without unreasonable effort because the Company is unable to reasonably predict certain items contained in the GAAP measures, including non-recurring and infrequent items that are not indicative of the Company's ongoing operations. Such items include, but are not limited to, impairment on depreciated real estate assets, net gain or loss on sale of real estate assets, stock-based compensation, casualty loss, non-Same-Store revenues and non-Same-Store operating expenses. These items are uncertain, depend on various factors and could have a material impact on the Company's GAAP results for the guidance period. |
Transactional Activity
During the three months ended June 30, 2024, the Company exercised the purchase options on three previously leased ISHC properties for approximately
Capital Markets and Balance Sheet Activity
As of June 30, 2024, the Company's total Pro-Rata indebtedness was
Subsequent to quarter end, on August 5, 2024 (180 days after the Company's initial listing of its common stock on the New York Stock Exchange), the Company completed the conversion of all of its shares of Class T common stock and Class I common stock into the Company's listed shares of common stock.
"We are increasing our full year 2024 Same-Store NOI growth and earnings guidance to reflect the occupancy gains and results we have achieved in 2024. The robust organic earnings growth thus far has allowed us to further improve our company's leverage profile with improving Net-Debt-to-Annualized-Adjusted EBITDA and we anticipate continuing to improve with disposition proceeds and incremental earnings growth," said Brian Peay, the Company's Chief Financial Officer.
Distribution
As previously announced, the Company's Board of Directors declared a cash distribution for the quarter ended June 30, 2024 of
Supplemental Information
The Company has disclosed supplemental information regarding its portfolio, financial position and results of operations as of June 30, 2024 and for the quarter then ended and certain other information, which is available on the Investor Relations section of the Company's website at https://ir.americanhealthcarereit.com.
Conference Call and Webcast Information
The Company will host a webcast and conference call at 1:00 p.m. Eastern Time on August 6, 2024. During the conference call, Company executives will review second quarter 2024 results, discuss recent events and conduct a question-and-answer period.
To join via webcast, investors may use the following link: https://events.q4inc.com/attendee/697424546.
Alternatively, to join via telephone, please pre-register at the following link.
A digital replay of the call will be available on the Investor Relations section of the Company's website at https://ir.americanhealthcarereit.com shortly after the conclusion of the call.
Forward-Looking Statements
Certain statements contained in this press release, including statements relating to the Company's expectations regarding its interest expense savings, balance sheet, net income or loss per share, FFO per share, NFFO per share, total portfolio Same-Store NOI growth, segment-level Same-Store NOI growth, occupancy, NOI growth, revenue growth, margin expansion, purchases and sales of assets, and plans for Trilogy may be considered forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The Company intends for all such forward-looking statements to be covered by the applicable safe harbor provisions for forward-looking statements contained in those acts. Such forward-looking statements generally can be identified by the use of forward-looking terminology, such as "may," "will," "can," "expect," "intend," "anticipate," "estimate," "believe," "continue," "possible," "initiatives," "focus," "seek," "objective," "goal," "strategy," "plan," "potential," "potentially," "preparing," "projected," "future," "long-term," "once," "should," "could," "would," "might," "uncertainty" or other similar words. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Any such forward-looking statements are based on current expectations, estimates and projections about the industry and markets in which the Company operates, and beliefs of, and assumptions made by, the Company's management and involve known and unknown risks and uncertainties that could cause actual results to differ materially from those expressed or implied therein, including, without limitation, risks disclosed in the Company's Annual Report on Form 10-K for the year ended December 31, 2023, and other periodic reports filed with the Securities and Exchange Commission. Except as required by law, the Company does not undertake any obligation to update or revise any forward-looking statements contained in this release.
Non-GAAP Financial Measures
The Company's reported results are presented in accordance with GAAP. The Company also discloses the following Non-GAAP financial measures: EBITDA, Adjusted EBITDA, NAREIT FFO, NFFO, NOI and Same-Store NOI. The Company believes these Non-GAAP financial measures are useful supplemental measures of its operating performance and used by investors and analysts to compare the operating performance of the Company between periods and to other REITs or companies on a consistent basis without having to account for differences caused by unanticipated and/or incalculable items. Definitions of the Non-GAAP financial measures used herein and reconciliations to the most directly comparable financial measure calculated in accordance with GAAP can be found at the end of this earnings release. See below for further information regarding the Company's Non-GAAP financial measures.
EBITDA and Adjusted EBITDA
Management uses earnings before interest, taxes, depreciation and amortization ("EBITDA") and Adjusted EBITDA to facilitate internal and external comparisons to our historical operating results and in making operating decisions. EBITDA and Adjusted EBITDA are widely used by investors, lenders, credit and equity analysts in the valuation, comparison, investment recommendations of companies. Additionally, EBITDA and Adjusted EBITDA are utilized by our Board of Directors to evaluate management. Neither EBITDA nor Adjusted EBITDA represents net income (loss) or cash flow provided from operating activities as determined in accordance with GAAP and should not be considered as alternative measures of profitability or liquidity. Finally, the EBITDA and Adjusted EBITDA may not be comparable to similarly entitled items reported by other REITs or other companies.
Funds from Operations (FFO) and Normalized Funds from Operations (NFFO)
We believe that the use of FFO, which excludes the impact of real estate-related depreciation and amortization and impairments, provides a further understanding of our operating performance to investors, industry analysts and our management, and when compared year over year, reflects the impact on our operations from trends in occupancy rates, rental rates, operating costs, general and administrative expenses and interest costs, which may not be immediately apparent from net income (loss). However, FFO and NFFO should not be construed to be (i) more relevant or accurate than the current GAAP methodology in calculating net income (loss) as an indicator of our operating performance, (ii) more relevant or accurate than GAAP cash flows from operations as an indicator of our liquidity or (iii) indicative of funds available to fund our cash needs, including our ability to make distributions to our stockholders. The method utilized to evaluate the value and performance of real estate under GAAP should be construed as a more relevant measure of operational performance and considered more prominently than the Non-GAAP FFO and NFFO measures and the adjustments to GAAP in calculating FFO and NFFO. Presentation of this information is intended to provide useful information to investors, industry analysts and management as they compare the operating performance metrics used by the REIT industry, although it should be noted that some REITs may use different methods of calculating funds from operations and normalized funds from operations, so comparisons with such REITs may not be meaningful.
Net Operating Income
We believe that NOI, Cash NOI, Pro-Rata Cash NOI and Same-Store NOI are appropriate supplemental performance measures to reflect the performance of our operating assets because NOI, Cash NOI, Pro-Rata Cash NOI and Same-Store NOI exclude certain items that are not associated with the operations of the properties. We believe that NOI, Cash NOI, Pro-Rata Cash NOI and Same-Store NOI are widely accepted measures of comparative operating performance in the real estate community. However, our use of the terms NOI, Cash NOI, Pro-Rata Cash NOI and Same-Store NOI may not be comparable to that of other real estate companies as they may have different methodologies for computing these amounts.
NOI, Cash NOI, Pro-Rata Cash NOI and Same-Store NOI are not equivalent to our net income (loss) as determined under GAAP and may not be a useful measure in measuring operational income or cash flows. Furthermore, NOI, Cash NOI, Pro-Rata Cash NOI and Same-Store NOI should not be considered as alternatives to net income (loss) as an indication of our operating performance or as an alternative to cash flows from operations as an indication of our liquidity. NOI, Cash NOI, Pro-Rata Cash NOI and Same-Store NOI should not be construed to be more relevant or accurate than the GAAP methodology in calculating net income (loss). NOI, Cash NOI, Pro-Rata Cash NOI and Same-Store NOI should be reviewed in conjunction with other measurements as an indication of our performance.
About American Healthcare REIT, Inc.
American Healthcare REIT, Inc. is a self-managed real estate investment trust that acquires, owns and operates a diversified portfolio of clinical healthcare real estate properties, focusing primarily on outpatient medical buildings, senior housing, skilled nursing facilities and other healthcare-related facilities. Its properties are located in
AMERICAN HEALTHCARE REIT, INC. CONDENSED CONSOLIDATED BALANCE SHEETS As of June 30, 2024 and December 31, 2023 (In thousands, except share and per share amounts) (Unaudited) | |||
June 30, 2024 | December 31, 2023 | ||
ASSETS | |||
Real estate investments, net | $ 3,509,526 | $ 3,425,438 | |
Debt security investment, net | 89,058 | 86,935 | |
Cash and cash equivalents | 52,087 | 43,445 | |
Restricted cash | 45,515 | 47,337 | |
Accounts and other receivables, net | 201,030 | 185,379 | |
Identified intangible assets, net | 179,458 | 180,470 | |
Goodwill | 234,942 | 234,942 | |
Operating lease right-of-use assets, net | 177,367 | 227,846 | |
Other assets, net | 155,632 | 146,141 | |
Total assets | $ 4,644,615 | $ 4,577,933 | |
LIABILITIES, REDEEMABLE NONCONTROLLING INTERESTS AND EQUITY | |||
Liabilities: | |||
Mortgage loans payable, net | $ 1,228,597 | $ 1,302,396 | |
Lines of credit and term loan, net | 783,873 | 1,223,967 | |
Accounts payable and accrued liabilities | 253,657 | 242,905 | |
Identified intangible liabilities, net | 5,533 | 6,095 | |
Financing obligations | 40,444 | 41,756 | |
Operating lease liabilities | 178,587 | 225,502 | |
Security deposits, prepaid rent and other liabilities | 49,811 | 76,134 | |
Total liabilities | 2,540,502 | 3,118,755 | |
Commitments and contingencies | |||
Redeemable noncontrolling interests | 220 | 33,843 | |
Equity: | |||
Stockholders' equity: | |||
Preferred stock, | — | — | |
Common Stock, | 644 | — | |
Class T common stock, | 195 | 194 | |
Class I common stock, | 467 | 467 | |
Additional paid-in capital | 3,278,806 | 2,548,307 | |
Accumulated deficit | (1,344,285) | (1,276,222) | |
Accumulated other comprehensive loss | (2,456) | (2,425) | |
Total stockholders' equity | 1,933,371 | 1,270,321 | |
Noncontrolling interests | 170,522 | 155,014 | |
Total equity | 2,103,893 | 1,425,335 | |
Total liabilities, redeemable noncontrolling interests and equity | $ 4,644,615 | $ 4,577,933 | |
AMERICAN HEALTHCARE REIT, INC. CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) For the Three and Six Months Ended June 30, 2024 and 2023 (In thousands, except share and per share amounts) (Unaudited) | |||||||
Three Months Ended June 30, | Six Months Ended June 30, | ||||||
2024 | 2023 | 2024 | 2023 | ||||
Revenues and grant income: | |||||||
Resident fees and services | $ 458,013 | $ 410,622 | $ 910,131 | $ 819,252 | |||
Real estate revenue | 46,568 | 50,568 | 93,983 | 94,164 | |||
Grant income | — | 6,381 | — | 6,381 | |||
Total revenues and grant income | 504,581 | 467,571 | 1,004,114 | 919,797 | |||
Expenses: | |||||||
Property operating expenses | 402,564 | 372,549 | 806,193 | 742,695 | |||
Rental expenses | 13,323 | 14,653 | 27,050 | 29,848 | |||
General and administrative | 11,746 | 11,774 | 23,574 | 24,827 | |||
Business acquisition expenses | 15 | 888 | 2,797 | 1,220 | |||
Depreciation and amortization | 45,264 | 44,701 | 88,031 | 89,371 | |||
Total expenses | 472,912 | 444,565 | 947,645 | 887,961 | |||
Other income (expense): | |||||||
Interest expense: | |||||||
Interest expense (including amortization of deferred financing costs, | (30,596) | (40,990) | (67,034) | (80,001) | |||
Gain in fair value of derivative financial instruments | 388 | 4,993 | 6,805 | 4,798 | |||
(Loss) gain on dispositions of real estate investments, net | (2) | (2,072) | 2,261 | (2,204) | |||
Loss from unconsolidated entities | (1,035) | (113) | (2,240) | (419) | |||
Gain on re-measurement of previously held equity interest | — | — | — | 726 | |||
Foreign currency gain (loss) | 82 | 1,068 | (344) | 2,076 | |||
Other income, net | 3,106 | 2,589 | 4,969 | 4,197 | |||
Total net other expense | (28,057) | (34,525) | (55,583) | (70,827) | |||
Income (loss) before income taxes | 3,612 | (11,519) | 886 | (38,991) | |||
Income tax expense | (686) | (348) | (964) | (491) | |||
Net income (loss) | 2,926 | (11,867) | (78) | (39,482) | |||
Net (income) loss attributable to noncontrolling interests | (947) | (316) | (1,835) | 1,427 | |||
Net income (loss) attributable to controlling interest | $ 1,979 | $ (12,183) | $ (1,913) | $ (38,055) | |||
Net income (loss) per share of Common Stock, Class T common | |||||||
Basic | $ 0.01 | $ (0.19) | $ (0.02) | $ (0.58) | |||
Diluted | $ 0.01 | $ (0.19) | $ (0.02) | $ (0.58) | |||
Weighted average number of shares of Common Stock, Class T common | |||||||
Basic | 130,532,144 | 66,033,345 | 117,413,643 | 66,029,779 | |||
Diluted | 130,689,889 | 66,033,345 | 117,413,643 | 66,029,779 | |||
Net income (loss) | $ 2,926 | $ (11,867) | $ (78) | $ (39,482) | |||
Other comprehensive income (loss): | |||||||
Foreign currency translation adjustments | 12 | 124 | (31) | 246 | |||
Total other comprehensive income (loss) | 12 | 124 | (31) | 246 | |||
Comprehensive income (loss) | 2,938 | (11,743) | (109) | (39,236) | |||
Comprehensive (income) loss attributable to noncontrolling interests | (947) | (316) | (1,835) | 1,427 | |||
Comprehensive income (loss) attributable to controlling interest | $ 1,991 | $ (12,059) | $ (1,944) | $ (37,809) | |||
AMERICAN HEALTHCARE REIT, INC. FFO and Normalized FFO Reconciliation For the Three and Six Months Ended June 30, 2024 and 2023 (In thousands, except share and per share amounts) (Unaudited) | |||||||
Three Months Ended June 30, | Six Months Ended June 30, | ||||||
2024 | 2023 | 2024 | 2023 | ||||
Net income (loss) | $ 2,926 | $ (11,867) | $ (78) | $ (39,482) | |||
Depreciation and amortization related to real estate — consolidated properties | 45,226 | 44,663 | 87,955 | 89,295 | |||
Depreciation and amortization related to real estate — unconsolidated entities | 186 | 95 | 372 | 158 | |||
Loss (gain) on dispositions of real estate investments, net — consolidated properties | 2 | 2,072 | (2,261) | 2,204 | |||
Net (income) loss attributable to noncontrolling interests | (947) | (316) | (1,835) | 1,427 | |||
Gain on re-measurement of previously held equity interest | — | — | — | (726) | |||
Depreciation, amortization, net gain/loss on dispositions and gain on re-measurement — noncontrolling interests | (5,647) | (7,073) | (11,109) | (13,611) | |||
NAREIT FFO attributable to controlling interest | $ 41,746 | $ 27,574 | $ 73,044 | $ 39,265 | |||
Business acquisition expenses | $ 15 | $ 888 | $ 2,797 | $ 1,220 | |||
Amortization of above- and below-market leases | 419 | 455 | 845 | 9,130 | |||
Amortization of closing costs — debt security investments | 80 | 68 | 156 | 133 | |||
Change in deferred rent | (556) | (180) | (1,145) | (240) | |||
Non-cash impact of changes to equity instruments | 2,765 | 1,593 | 4,700 | 2,665 | |||
Capitalized interest | (71) | (54) | (205) | (80) | |||
Loss on debt extinguishments | — | — | 1,280 | — | |||
Gain in fair value of derivative financial instruments | (388) | (4,993) | (6,805) | (4,798) | |||
Foreign currency (gain) loss | (82) | (1,068) | 344 | (2,076) | |||
Adjustments for unconsolidated entities | (138) | (179) | (248) | (253) | |||
Adjustments for noncontrolling interests | (50) | 43 | 75 | (590) | |||
Normalized FFO attributable to controlling interest | $ 43,740 | $ 24,147 | $ 74,838 | $ 44,376 | |||
Weighted average common shares outstanding — diluted | 130,689,889 | 66,033,345 | 117,413,643 | 66,029,779 | |||
Net income (loss) per common share attributable to controlling interest — diluted | $ 0.01 | $ (0.19) | $ (0.02) | $ (0.58) | |||
NAREIT FFO per common share attributable to controlling interest — diluted | $ 0.32 | $ 0.42 | $ 0.62 | $ 0.59 | |||
Normalized FFO per common share attributable to controlling interest — diluted | $ 0.33 | $ 0.37 | $ 0.64 | $ 0.67 | |||
AMERICAN HEALTHCARE REIT, INC. Adjusted EBITDA Reconciliation For the Three Months Ended June 30, 2024 (In thousands) (Unaudited)
| ||
Net Income | $ 2,926 | |
Interest expense (including amortization of deferred financing costs, | 30,596 | |
Income tax expense | 686 | |
Depreciation and amortization (including amortization of leased assets | 45,750 | |
EBITDA | $ 79,958 | |
Loss from unconsolidated entities | 1,035 | |
Straight line rent and amortization of above/below market leases | (329) | |
Non-cash stock-based compensation expense | 2,765 | |
Business acquisition expenses | 15 | |
Loss on dispositions of real estate investments, net | 2 | |
Foreign currency gain | (82) | |
Gain in fair value of derivative financial instruments | (388) | |
Non-recurring one-time items | (489) | |
Adjusted EBITDA | $ 82,487 | |
AMERICAN HEALTHCARE REIT, INC. NOI and Cash NOI Reconciliation For the Three and Six Months Ended June 30, 2024 and 2023 (In thousands) (Unaudited) | |||||||
Three Months Ended June 30, | Six Months Ended June 30, | ||||||
2024 | 2023 | 2024 | 2023 | ||||
Net income (loss) | $ 2,926 | $ (11,867) | $ (78) | $ (39,482) | |||
General and administrative | 11,746 | 11,774 | 23,574 | 24,827 | |||
Business acquisition expenses | 15 | 888 | 2,797 | 1,220 | |||
Depreciation and amortization | 45,264 | 44,701 | 88,031 | 89,371 | |||
Interest expense | 30,596 | 40,990 | 67,034 | 80,001 | |||
Gain in fair value of derivative financial instruments | (388) | (4,993) | (6,805) | (4,798) | |||
Loss (gain) on dispositions of real estate investments, net | 2 | 2,072 | (2,261) | 2,204 | |||
Loss from unconsolidated entities | 1,035 | 113 | 2,240 | 419 | |||
Gain on re-measurement of previously held equity interest | — | — | — | (726) | |||
Foreign currency (gain) loss | (82) | (1,068) | 344 | (2,076) | |||
Other income, net | (3,106) | (2,589) | (4,969) | (4,197) | |||
Income tax expense | 686 | 348 | 964 | 491 | |||
Net operating income | $ 88,694 | $ 80,369 | $ 170,871 | $ 147,254 | |||
Grant Income | — | (6,381) | — | (6,381) | |||
Total NOI (excluding Grant Income) | $ 88,694 | $ 73,988 | $ 170,871 | $ 140,873 | |||
Straight line rent | (748) | (993) | (1,880) | (2,083) | |||
Facility rental expense | 7,888 | 9,717 | 16,728 | 19,362 | |||
Other non-cash adjustments | 315 | 718 | 706 | 9,332 | |||
COVID subsidy | — | — | — | (143) | |||
Cash NOI attributable to noncontrolling interests (1) | (13,014) | (10,746) | (25,441) | (21,292) | |||
Cash NOI | $ 83,135 | $ 72,684 | $ 160,984 | $ 146,049 | |||
____________
(1) | All quarters are based upon current quarter's ownership percentage. |
AMERICAN HEALTHCARE REIT, INC. Same-Store NOI Reconciliation For the Three and Six Months Ended June 30, 2024 and 2023 (In thousands) (Unaudited) | |||||||
Three Months Ended June 30, | Six Months Ended June 30, | ||||||
2024 | 2023 | 2024 | 2023 | ||||
ISHC | |||||||
NOI (excluding Grant Income) | $ 45,308 | $ 34,160 | $ 87,288 | $ 67,569 | |||
Facility rental expense | 7,888 | 9,717 | 16,728 | 19,362 | |||
Cash NOI attributable to noncontrolling interest (1) | (12,767) | (10,533) | (24,964) | (20,867) | |||
Cash NOI (2) | $ 40,429 | $ 33,344 | $ 79,052 | $ 66,064 | |||
New acquisitions/dispositions/transitions (2) | (4,565) | (4,438) | (9,445) | (9,025) | |||
Same-Store NOI (2) | $ 35,864 | $ 28,906 | $ 69,607 | $ 57,039 | |||
Outpatient Medical | |||||||
NOI | $ 21,011 | $ 22,713 | $ 41,989 | $ 45,788 | |||
Straight line rent | (128) | (327) | (286) | (720) | |||
Other non-cash adjustments | 82 | 378 | 246 | 565 | |||
Cash NOI | $ 20,965 | $ 22,764 | $ 41,949 | $ 45,633 | |||
New acquisitions/dispositions/transitions | (4) | (1,794) | (79) | (4,041) | |||
Non-Core Properties | (853) | (787) | (1,687) | (1,539) | |||
Same-Store NOI | $ 20,108 | $ 20,183 | $ 40,183 | $ 40,053 | |||
SHOP | |||||||
NOI | $ 10,141 | $ 3,913 | $ 16,650 | $ 8,988 | |||
Other non-cash adjustments | — | 35 | — | (5) | |||
COVID subsidies | — | — | — | (143) | |||
Cash NOI attributable to noncontrolling interests (1) | (60) | (30) | (106) | (60) | |||
Cash NOI | $ 10,081 | $ 3,918 | $ 16,544 | $ 8,780 | |||
New acquisitions/dispositions/transitions | (1,891) | 1,480 | (1,107) | 2,037 | |||
Development conversion | 510 | 418 | 1,050 | 830 | |||
Other normalizing adjustments | 100 | 86 | 100 | 86 | |||
Same-Store NOI | $ 8,800 | $ 5,902 | $ 16,587 | $ 11,733 | |||
Triple-Net Leased Properties | |||||||
NOI | $ 12,234 | $ 13,202 | $ 24,944 | $ 18,528 | |||
Straight line rent | (620) | (666) | (1,594) | (1,363) | |||
Other non-cash adjustments | 233 | 305 | 460 | 8,772 | |||
Cash NOI attributable to noncontrolling interest (1) | (187) | (183) | (371) | (365) | |||
Cash NOI | $ 11,660 | $ 12,658 | $ 23,439 | $ 25,572 | |||
Debt security investment | (2,039) | (2,045) | (4,120) | (4,015) | |||
New acquisitions/dispositions/transitions | — | (1,271) | — | (2,924) | |||
Non-Core Properties | (373) | (352) | (746) | (704) | |||
Same-Store NOI | $ 9,248 | $ 8,990 | $ 18,573 | $ 17,929 | |||
AMERICAN HEALTHCARE REIT, INC. Same-Store NOI Reconciliation – (Continued) For the Three and Six Months Ended June 30, 2024 and 2023 (In thousands) (Unaudited) | |||||||
Three Months Ended June 30, | Six Months Ended June 30, | ||||||
2024 | 2023 | 2024 | 2023 | ||||
Total | |||||||
NOI (excluding Grant Income) | $ 88,694 | $ 73,988 | $ 170,871 | $ 140,873 | |||
Straight line rent | (748) | (993) | (1,880) | (2,083) | |||
Facility rental expense | 7,888 | 9,717 | 16,728 | 19,362 | |||
Other non-cash adjustments | 315 | 718 | 706 | 9,332 | |||
COVID subsidies | — | — | — | (143) | |||
Cash NOI attributable to noncontrolling interests (1) | (13,014) | (10,746) | (25,441) | (21,292) | |||
Cash NOI (2) | $ 83,135 | $ 72,684 | $ 160,984 | $ 146,049 | |||
Debt security investment | (2,039) | (2,045) | (4,120) | (4,015) | |||
New acquisitions/dispositions/transitions (2) | (6,460) | (6,023) | (10,631) | (13,953) | |||
Development conversion | 510 | 418 | 1,050 | 830 | |||
Non-Core Properties | (1,226) | (1,139) | (2,433) | (2,243) | |||
Other normalizing adjustments (2) | 100 | 86 | 100 | 86 | |||
Same-Store NOI (2) | $ 74,020 | $ 63,981 | $ 144,950 | $ 126,754 | |||
____________
(1) | All quarters are based upon current quarter's ownership percentage. |
(2) | Prior quarters information has been updated to reflect the increase in ownership to |
AMERICAN HEALTHCARE REIT, INC. Same-Store Revenue Reconciliation For the Three Months Ended and Six Months Ended June 30, 2024 and 2023 (In thousands) (Unaudited) | |||||||
Three Months Ended June 30, | Six Months Ended June 30, | ||||||
2024 | 2023 | 2024 | 2023 | ||||
ISHC | |||||||
GAAP revenue and Grant Income | $ 393,774 | $ 369,237 | $ 786,896 | $ 731,007 | |||
Grant Income | — | (6,381) | — | (6,381) | |||
Cash revenue attributable to noncontrolling interest (1) | (94,506) | (87,087) | (188,855) | (173,912) | |||
Cash revenue (2) | 299,268 | 275,769 | 598,041 | 550,714 | |||
Revenue attributable to non-Same-Store properties (2) | (95,237) | (86,515) | (189,725) | (171,252) | |||
Same-Store revenue (2) | $ 204,031 | $ 189,254 | $ 408,316 | $ 379,462 | |||
Outpatient Medical | |||||||
GAAP revenue | $ 33,682 | $ 36,640 | $ 67,749 | $ 74,123 | |||
Straight line rent | (128) | (327) | (286) | (720) | |||
Other non-cash adjustments | (267) | (19) | (452) | (138) | |||
Cash revenue | 33,287 | 36,294 | 67,011 | 73,265 | |||
Revenue attributable to non-Same-Store properties | — | (3,182) | (155) | (7,165) | |||
Revenue attributable to Non-Core Properties | (1,264) | (1,186) | (2,530) | (2,335) | |||
Same-Store revenue | $ 32,023 | $ 31,926 | $ 64,326 | $ 63,765 | |||
SHOP | |||||||
GAAP revenue | $ 64,239 | $ 47,766 | $ 123,235 | $ 94,626 | |||
Cash revenue attributable to noncontrolling interests (1) | (291) | (357) | (567) | (736) | |||
Cash revenue | 63,948 | 47,409 | 122,668 | 93,890 | |||
Revenue attributable to non-Same-Store properties | (20,409) | (8,342) | (36,462) | (15,955) | |||
Revenue attributable to development conversion | (415) | (478) | (685) | (1,069) | |||
Same-Store revenue | $ 43,124 | $ 38,589 | $ 85,521 | $ 76,866 | |||
Triple-Net Leased Properties | |||||||
GAAP revenue | $ 12,886 | $ 13,928 | $ 26,234 | $ 20,041 | |||
Straight line rent | (620) | (666) | (1,594) | (1,363) | |||
Other non-cash adjustments | 212 | 266 | 422 | 8,734 | |||
Cash revenue attributable to noncontrolling interest (1) | (186) | (184) | (372) | (366) | |||
Cash revenue | 12,292 | 13,344 | 24,690 | 27,046 | |||
Debt security investment | (2,039) | (2,045) | (4,120) | (4,015) | |||
Revenue attributable to non-Same-Store properties | — | (1,369) | — | (3,174) | |||
Revenue attributable to Non-Core Properties | (463) | (448) | (921) | (925) | |||
Same-Store revenue | $ 9,790 | $ 9,482 | $ 19,649 | $ 18,932 | |||
AMERICAN HEALTHCARE REIT, INC. Same-Store Revenue Reconciliation - (Continued) For the Three Months Ended and Six Months Ended June 30, 2024 and 2023 (In thousands) (Unaudited) | |||||||
Three Months Ended June 30, | Six Months Ended June 30, | ||||||
2024 | 2023 | 2024 | 2023 | ||||
Total | |||||||
GAAP revenue and Grant Income | $ 504,581 | $ 467,571 | $ 1,004,114 | $ 919,797 | |||
Straight line rent | (748) | (993) | (1,880) | (2,083) | |||
Other non-cash adjustments | (55) | 247 | (30) | 8,596 | |||
Grant Income | — | (6,381) | — | (6,381) | |||
Cash revenue attributable to noncontrolling interests (1) | (94,983) | (87,628) | (189,794) | (175,014) | |||
Cash revenue (2) | 408,795 | 372,816 | 812,410 | 744,915 | |||
Debt security investment | (2,039) | (2,045) | (4,120) | (4,015) | |||
Revenue attributable to non-Same-Store properties (2) | (115,646) | (99,408) | (226,342) | (197,546) | |||
Revenue attributable to development conversion | (415) | (478) | (685) | (1,069) | |||
Revenue attributable to Non-Core Properties | (1,727) | (1,634) | (3,451) | (3,260) | |||
Same-Store revenue (2) | $ 288,968 | $ 269,251 | $ 577,812 | $ 539,025 | |||
____________
(1) | All quarters are based upon current quarter's ownership percentage. |
(2) | Prior quarters information has been updated to reflect the increase in ownership to |
AMERICAN HEALTHCARE REIT, INC. Earnings Guidance Reconciliation For the Year Ending December 31, 2024 (Dollars and shares in millions, except per share amounts) (Unaudited) | |||||||
Revised | Full | Previous | |||||
Year 2024 Guidance | |||||||
Low | High | Low | High | ||||
Net (loss) income attributable to common stockholders | $ (8.80) | $ (3.05) | $ (4.15) | $ 3.19 | |||
Depreciation and amortization(1) | 154.50 | 154.50 | 147.26 | 147.26 | |||
NAREIT FFO attributable to common stockholders | $ 147.30 | $ 151.30 | $ 143.11 | $ 150.45 | |||
Amortization other intangible assets(1) | $ 1.80 | $ 1.80 | $ 1.66 | $ 1.66 | |||
Change in deferred rent(1) | (1.10) | (1.10) | (0.42) | (0.42) | |||
Non-cash impact of changes to equity plan(1) | 9.40 | 9.40 | 6.04 | 6.04 | |||
Other adjustments | (3.20) | (3.20) | (0.80) | (0.80) | |||
Normalized FFO attributable to common stockholders | $ 154.20 | $ 158.20 | $ 149.58 | $ 156.92 | |||
Net (loss) income per common share — diluted | $ (0.07) | $ (0.02) | $ (0.03) | $ 0.03 | |||
NAREIT FFO per common share — diluted | $ 1.17 | $ 1.22 | $ 1.13 | $ 1.19 | |||
Normalized FFO per common share — diluted | $ 1.23 | $ 1.27 | $ 1.18 | $ 1.24 | |||
Weighted average diluted shares | 124.5 | 124.5 | 126.6 | 126.6 | |||
Total Portfolio Same-Store NOI growth | 12.00 % | 14.00 % | 5.00 % | 7.00 % | |||
Segment-Level Same-Store NOI growth | |||||||
ISHC | 18.00 % | 20.00 % | 8.00 % | 10.00 % | |||
OM | (0.50 %) | — % | (0.50 %) | — % | |||
SHOP | 45.00 % | 50.00 % | 25.00 % | 30.00 % | |||
Triple-Net Leased Properties | 1.00 % | 3.00 % | 1.00 % | 3.00 % | |||
____________
(1) | Amounts presented net of noncontrolling interests' share and AHR's share of unconsolidated entities. |
Definitions
Adjusted EBITDA: EBITDA excluding the impact of gain or loss from unconsolidated entities, straight line rent and amortization of above/below market leases, non-cash stock-based compensation expense, business acquisition expenses, gain or loss on sales of real estate investments, unrealized foreign currency gain or loss, change in fair value of derivative financial instruments, impairments of real estate investments, impairment of intangible assets and goodwill, and non-recurring one-time items.
Cash NOI: NOI excluding the impact of, without duplication, (1) non-cash items such as straight-line rent and the amortization of lease intangibles, (2) third-party facility rent payments and (3) other items set forth in the Cash NOI reconciliation included herein. Both Cash NOI and Same-Store NOI include ownership and other adjustments.
EBITDA: A Non-GAAP financial measure that is defined as earnings before interest, taxes, depreciation and amortization.
GAAP revenue: Revenue recognized in accordance with Generally Accepted Accounting Principles ("GAAP"), which includes straight line rent and other non-cash adjustments.
ISHC: Integrated senior health campuses include a range of senior care, including independent living, assisted living, memory care, skilled nursing services and certain ancillary businesses. Integrated senior health campuses are predominantly operated utilizing a RIDEA structure.
NAREIT FFO or FFO: Funds from operations attributable to controlling interest; a Non-GAAP financial measure, consistent with the standards established by the White Paper on FFO approved by the Board of Governors of NAREIT (the "White Paper"). The White Paper defines FFO as net income (loss) computed in accordance with GAAP, excluding gains or losses from sales of certain real estate assets, gains or losses upon consolidation of a previously held equity interest, and impairment write-downs of certain real estate assets and investments, plus depreciation and amortization related to real estate, after adjustments for unconsolidated partnerships and joint ventures. While impairment charges are excluded from the calculation of FFO as described above, investors are cautioned that impairments are based on estimated future undiscounted cash flows. Adjustments for unconsolidated partnerships and joint ventures are calculated to reflect FFO.
Net Debt: Total long-term debt, excluding operating lease liabilities, less cash and cash equivalents and restricted cash pertaining to debt.
NOI: Net operating income; a Non-GAAP financial measure that is defined as net income (loss), computed in accordance with GAAP, generated from properties before general and administrative expenses, business acquisition expenses, depreciation and amortization, interest expense, gain or loss in fair value of derivative financial instruments, gain or loss on dispositions, impairment of real estate investments, impairment of intangible assets and goodwill, income or loss from unconsolidated entities, gain on re-measurement of previously held equity interest, foreign currency gain or loss, other income or expense and income tax benefit or expense.
Non-Core Properties: Assets that have been deemed not essential to generating future economic benefit or value to our day-to-day operations and/or are projected to be sold.
Normalized FFO attributable to controlling interest or NFFO: FFO further adjusted for the following items included in the determination of GAAP net income (loss): expensed acquisition fees and costs, which we refer to as business acquisition expenses; amounts relating to changes in deferred rent and amortization of above and below-market leases (which are adjusted in order to reflect such payments from a GAAP accrual basis); the non-cash impact of changes to our equity instruments; non-cash or non-recurring income or expense; the noncash effect of income tax benefits or expenses; capitalized interest; impairment of intangible assets and goodwill; amortization of closing costs on debt investments; mark-to-market adjustments included in net income (loss); gains or losses included in net income (loss) from the extinguishment or sale of debt, hedges, foreign exchange, derivatives or securities holdings where trading of such holdings is not a fundamental attribute of the business plan; and after adjustments for consolidated and unconsolidated partnerships and joint ventures, with such adjustments calculated to reflect Normalized FFO on the same basis.
Occupancy: With respect to OM, the percentage of total rentable square feet leased and occupied, including month-to-month leases, as of the date reported. With respect to all other property types, occupancy represents average quarterly operating occupancy based on the most recent quarter of available data. The Company uses unaudited, periodic financial information provided solely by tenants to calculate occupancy and has not independently verified the information. Occupancy metrics are reflected at our Pro-Rata share.
Outpatient Medical or OM: Outpatient Medical buildings.
Pro-Rata: As of June 30, 2024, we owned and/or operated our 126 integrated senior health campuses through entities of which we owned
RevPOR: Revenue per occupied room. RevPOR is calculated as total revenue generated by occupied rooms divided by the number of occupied rooms.
RIDEA: Used to describe properties within the portfolio that utilize the RIDEA structure as described in "RIDEA structure".
RIDEA structure: A structure permitted by the REIT Investment Diversification and Empowerment Act of 2007, pursuant to which we lease certain healthcare real estate properties to a wholly-owned taxable REIT subsidiary ("TRS"), which in turn contracts with an eligible independent contractor ("EIK") to operate such properties for a fee. Under this structure, the EIK receives management fees, and the TRS receives revenue from the operation of the healthcare real estate properties and retains, as profit, any revenue remaining after payment of expenses (including intercompany rent paid to us and any taxes at the TRS level) necessary to operate the property. Through the RIDEA structure, in addition to receiving rental revenue from the TRS, we retain any after-tax profit from the operation of the healthcare real estate properties and benefit from any improved operational performance while bearing the risk of any decline in operating performance at the properties.
Same-Store or SS: Properties owned or consolidated the full year in both comparison years and that are not otherwise excluded. Properties are excluded from Same-Store if they are: (1) sold, classified as held for sale or properties whose operations were classified as discontinued operations in accordance with GAAP; (2) impacted by materially disruptive events, such as flood or fire for an extensive period of time; or (3) scheduled to undergo or currently undergoing major expansions/renovations or business model transitions or have transitioned business models after the start of the prior comparison period.
Same-Store NOI or SS NOI: Cash NOI for our Same-Store properties. Same-Store NOI is used to evaluate the operating performance of our properties using a consistent population which controls for changes in the composition of our portfolio. Both Cash NOI and Same-Store NOI include ownership and other adjustments.
SHOP: Senior housing operating properties.
Square Feet or Sq. Ft.: Net rentable square feet calculated utilizing Building Owners and Managers Association measurement standards.
Total Debt: The principal balances of the Company's revolving credit facility, term loans and secured indebtedness as reported in the Company's consolidated financial statements.
Trilogy: Trilogy Investors, LLC; one of our consolidated joint ventures, in which we indirectly owned a
Trilogy REIT Holdings: Trilogy REIT Holdings, LLC; the joint venture between the Company and NorthStar Healthcare Income, Inc. that owns the interest in Trilogy or Trilogy Investors, LLC.
Triple-net leased: A lease where the tenant is responsible for making rent payments, maintaining the leased property and paying property taxes and other expenses.
Contact: Alan Peterson
Email: investorrelations@ahcreit.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/american-healthcare-reit-ahr-announces-second-quarter-2024-results-increases-full-year-2024-guidance-302214670.html
SOURCE American Healthcare REIT, Inc.
FAQ
What was American Healthcare REIT's (AHR) Same-Store NOI growth in Q2 2024?
How did American Healthcare REIT (AHR) revise its full-year 2024 guidance?
What was American Healthcare REIT's (AHR) Normalized FFO per share in Q2 2024?
How did American Healthcare REIT's (AHR) SHOP segment perform in Q2 2024?
